Phospho-MARCKS (Ser170) Rabbit Polyclonal Antibody (FITC)
Phospho-MARCKS (Ser170) Rabbit Polyclonal Antibody (FITC) is an FITC conjugated antibody targeting MARCKS. This antibody is suitable for IF. It exhibits reactivity with Mouse, Rat samples.
Product Specifications
Product Name Alternative
MARCKS (phospho Ser170) ; MARCKS (phospho S170) ; 80 kDa protein; 80K L; 80K L protein; 80K-L protein; 80KL; 81 kDa protein, light chain; light chain; MACS; MARCKS; MARCS; MARCS_HUMAN; MGC52672; myristoylated alanine rich C kinase substrate; Myristoylated alanine rich protein kinase C substrate (MARCKS, 80K L) ; Myristoylated alanine rich protein kinase C substrate; Myristoylated alanine-rich C-kinase substrate; phosphomyristin; PKCSL; PRKCSL; protein kinase C substrate 80 kDa protein light chain; Protein kinase C substrate.
Reactivity
Mouse, Rat
Immunogen
KLH conjugated Synthesised phosphopeptide derived from human MARCKS around the phosphorylation site of Ser170 GF (p-S) FK
Target
MARCKS
Clonality
Polyclonal
Conjugation
FITC
Field of Research
Musculoskeletal & Connective Tissue Research
Purification
Affinity purified by Protein A
Concentration
1mg/ml
Dilution
IF=1:100-500
Storage Conditions
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Notes
For research use only.
Prediction Reactivity
Bovine, Canine, Gallus, Human
Tested Applications
IF
Host or Source
Rabbit
Preservative
0.01M TBS (pH7.4) with 1% rAlbumin, 0.02% Proclin300 and 50% Glycerol.
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740266-500 1x 500 µL
Human IgG Immunoglobulin (IG266), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040745-500 1x 500 µL
CD45 / LCA (2B11 + PD7/26), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040676-500 1x 500 µL
MUC18 / Mucin 18 / CD146 (OJ79c), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401045-100 1x 100 µL
CD16 (C16/1045), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 